Concepedia

Yuangang Su

YS

23

Publications

602

Citations

15

H-Index

1994

Active since

Affiliations

Guangxi Medical University(Current)

First Affiliated Hospital of GuangXi Medical University

The University of Western Australia

Chinese Academy of Sciences

Shenzhen Institutes of Advanced Technology

Yuangang Su is an author at Guangxi Medical University specializing in medicine, osteoporosis, and cell biology.

ORCID

Top concepts

Publications per year

1994–2024

23

Publications

23

Oroxylin A reduces osteoclast formation and bone resorption via suppressing RANKL-induced ROS and NFATc1 activation

Yansi Xian, Yuangang Su, Jiamin Liang et al. · Biochemical Pharmacology · 2021 · 84 citations · Full text

Alpinetin ameliorates bone loss in LPS-induced inflammation osteolysis via ROS mediated P38/PI3K signaling pathway

Linhua Wei, Weiwei Chen, Linke Huang et al. · Pharmacological Research · 2022 · 81 citations

, , +11

Pharmacology-based molecular docking of 4-methylcatechol and its role in RANKL-mediated ROS/Keap1/Nrf2 signalling axis and osteoclastogenesis

Yang Xu, Dezhi Song, Yuangang Su et al. · Biomedicine & Pharmacotherapy · 2023 · 41 citations · Full text

Inhibitory effects of biochanin A on titanium particle‐induced osteoclast activation and inflammatory bone resorption via NF‐κB and MAPK pathways

Shijie Liao, Wenyu Feng, Yun Liu et al. · Journal of Cellular Physiology · 2020 · 35 citations

Daphnetin attenuates LPS‐induced osteolysis and RANKL mediated osteoclastogenesis through suppression of ERK and NFATc1 pathways

Zuoxing Wu, Hailun Wu, Chen Li et al. · Journal of Cellular Physiology · 2019 · 32 citations

, , +20

Rows per page

1–5 of 23